Ondansetron Injection, USP, 4 mg/2 mL (2 mg/mL), 2 mL Single-dose Vial, Rx Only, Sterile, Hospira Inc., Lake Forest IL 60045, USA, NDC 0409-4755-03
Published November 27, 2013 · Recall initiated: September 24, 2013
Summary
FDA records drug Class II recall D-013-2014, published November 27, 2013 and initiated September 24, 2013. Recalling firm: Hospira Inc.; Status: Terminated; Reported quantity: 681,400 vials; Lot: 29-484-DK* and 29-510-DK* Exp 05/01/2015 (lot number may be proceeded with an 01). Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Particular Matter: Potential vendor glass issue - glass spiticules (glass strands) were identified during site inspection of the vials.
What to do
Voluntary: Firm initiated · Letter
Get an email if ONDANSETRON has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- ONDANSETRON
- Manufacturer
- Hospira Inc.
- Distributor
- Nationwide and Puerto Rico
- UPC
- 040947550329
- Lot
- 29-484-DK* and 29-510-DK* Exp 05/01/2015 (lot number may be proceeded with an 01)
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAOndansetron Orally Disintegrating Tablets, USP, 4mg, 30 Tablets (3 blistercards each containing 10 tablets),January 7, 2026
- FDAONDANSETRON INJECTION, USP, 4 mg/ 2 mL (2 mg/mL), For IM or IV Use, Single Dose 2 mL Vials, Rx only. APPDecember 17, 2014
- FDAMetoclopramide Injection, USP 10 mg (5mg/mL), 2 mL Single-dose Vial, Rx Only, Sterile, Hospira Inc., LakeNovember 27, 2013
- FDAAldactone (spironolactone) tablets, USP, 100 mg, 100-count bottles, Rx only, Distributed by G.D. Searle,November 27, 2013
- FDASpironolactone tablets, USP 50 mg, Rx only, 100 count bottle, Distributed By: Greenstone LLC, Peapack, NJNovember 27, 2013
- FDAOndansetron Injection, USP, 4mg/2mL, (2mg/ml), 2mL single-dose Fliptop Vial, Rx only, Sterile, NDCAugust 14, 2013
Questions about this recall
Was Ondansetron Injection, USP, 4 mg/2 mL (2 mg/mL), 2 mL Single-dose Vial, Rx Only, Sterile, Hospira Inc., Lake Forest IL 60045, USA, NDC 0409-4755-03 recalled?
Yes. FDA published recall D-013-2014 on November 27, 2013. Reported hazard: Presence of Particular Matter: Potential vendor glass issue - glass spiticules (glass strands) were identified during site inspection of the vials.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: ONDANSETRON. UPC: 040947550329.